NDRA - ENDRA Life Sciences Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

NDRA

ENDRA LIFE SCIENCES INC.

NASDAQ

$5.00

▼ DOWN 7.49% (-0.41)

KEY STATISTICS

Market Cap$6.36 M

52w High$9.85

52w Low$2.96

Dividend Yield—

Frequency—

P/E-0.64

Volume24.37K

Shares Out.1.27M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Alexander Y. Tokman

COMPENSATION 2026

Salary$387,859

Stock Awards$0

Incentive Plan Pay$0

All Other Comp.$587

Total$646,787

ABOUT

SECTOR

Healthcare

WENT PUBLIC

June 30, 2017

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

UPCOMING EARNINGS

DateNov 13, 2026

DayFriday

Rev. Est.$100.00K

NOV

FRI

SPLIT RECORD

DATE	TYPE	RATIO
2024-11-07	Reverse	1:35
2024-08-20	Reverse	1:50
2022-12-09	Reverse	1:20

PRICE

$5.00 ▼ DOWN 7.49% (−$0.41)

OVERLAYS

About ENDRA Life Sciences Inc.

https://www.endrainc.com ↗

ENDRA Life Sciences develops thermo-acoustic ultrasound and imaging technologies for medical diagnostics and treatment monitoring, including applications for liver disease, surgery, vascular imaging, and internal medical assessments.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT ENDRA LIFE SCIENCES INC. IS KNOWN FOR

TAEUS® Liver Imaging Device

TAEUS® is a non-invasive medical imaging device that measures liver fat content, offering MRI-like diagnostics at a lower cost to help assess and monitor steatotic liver disease.